LOX and head and neck cancer: The enzyme lysyl oxidase (LOX), which initiates cross-linking in the extracellular space, is elevated in response to hypoxic microenvironments and various cytokines (41, 42), and is associated with metastasis and poor survival in breast and head-and-neck cancer (43).